ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,359 | +85.2% | 896 | +79.6% | 0.00% | – |
| Q2 2023 | $9,915 | +38.8% | 499 | +19.7% | 0.00% | – |
| Q1 2023 | $7,143 | -12.5% | 417 | 0.0% | 0.00% | – |
| Q4 2022 | $8,161 | +16.6% | 417 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +16.7% | 417 | 0.0% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 417 | +58.0% | 0.00% | – |
| Q1 2022 | $4,000 | – | 264 | +1100.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 22 | +22.2% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 18 | -41.9% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 31 | -3.1% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 32 | -42.9% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 56 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 56 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |